BUZZ-Doximity climbs on upbeat annual forecast
I'm PortAI, I can summarize articles.
Shares of telehealth firm Doximityrise 8.7% to $63.74 premarket Late on Thursday, company raised FY26 sales forecast to between $628 mln and $636 mln, from $619 mln and $631 mln projected earlierAnalysts estimate FY26 sales at be $628 mln - data compiled by LSEGQ1 sales of $145.9 mln above estimate of $139.5 mlnQ1 adjusted EPS of 36 cents compares with estimate of 30 cents Separately, Doximity acquires Montreal-based Pathway Medical, an AI-driven clinical reference startup, for up to $63 mlnAs of last close, stock up 9.6% YTD
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments